The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that ...

The approval was supported by data from the randomized, double-blind, placebo-controlled, phase 3 ARANOTE trial.

Inverse correlation seen for arterial flow mediated dilation with smoking frequency and amount of THC ingested.

Findings seen in women with moderate-to-severe vasomotor symptoms associated with endocrine therapy for HR-positive breast cancer.

The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for ziftomenib as a treatment for adult patients with relapsed or refractory (R/R) acute myeloid ...

Protective association seen between GLP-1 receptor agonist use and colon and rectal cancers in adults with obesity and diabetes ...

A phase 1 trial, LUMINA, is currently underway and is evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of AMX0114 in approximately 48 patients with ALS.

The summary below gives an overview of important additions and changes MPR has made to its drug database through the end of May 2025. The chart below provides highlights of key monograph updates made ...

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for linerixibat for the treatment of cholestatic pruritus in patients with primary biliary cholangitis ...

It's not likely that shoppers will come across any fresh tomatoes from the recalled batch, according to the FDA.

Patients who would benefit most from surgery and are least likely to benefit from continued medical therapy alone should be identified ...

Clinically relevant but not statistically significant improvement seen in anxiety and fatigue versus usual services.